The Therapeutic Effects of Cannabinoids in Neurodegenerative Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: closed (10 June 2022) | Viewed by 10620
Special Issue Editor
Interests: Alzheimer’s disease; cannabinoid receptor; cannabis; endocannabinoid; Huntington’s disease; neuroprotection; peptide cannabinoids; Parkinson’s disease; Prion disease; Spinocerebellar ataxia
Special Issue Information
Dear Colleagues,
This Special Issue focuses on cannabinoids in the broadest sense and their therapeutic actions in both models and patient settings linked to neurodegenerative diseases. There are numerous neurodegenerative diseases, plus pathologies and symptoms associated with these that can potentially be treated by cannabinoids. As well as the obvious neuroprotection routes, there are also symptom relief treatments that have huge potential. The development of cannabinoids as therapies for neurodegenerative diseases is a rapidly expanding field. The lack of effective therapies for long-term control of many neurodegenerative disorders has led to a search for new ways to exploit chemicals that can easily cross the blood–brain barrier. Among the most exciting class of chemicals that readily cross the blood–brain barrier are cannabinoids. The presence of cannabinoid receptors combined with suggested neuroprotective actions mediated by actions at the neuronal cannabinoid receptors has made this area a hot bed of development covered in this Special Issue. The plethora of symptoms associated with neurodegenerative diseases and the use of cannabinoids to relieve these symptoms is another up-and-coming area that will be covered.
Therefore, I am taking the liberty to invite all authors from the cannabinoid and neurodegenerative disease fields to contribute. Review and research articles that summarize and investigate the therapeutic role of cannabinoids in processes underlying the pathology of neurodegenerative disease, plus associated symptomatic changes are very welcome. Treatments that modify the endogenous cannabinoid system are another area in which papers are sought. In particular, the Special Issue aims to translate the results of basic research into the treatment of various neurodegenerative diseases. Articles demonstrating the potential of cannabinoids in neurodegenerative disorders not previously linked with cannabinoid therapy are particularly welcome alongside articles suggesting potential of novel cannabinoids.
Dr. Nathaniel Milton
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- cannabinoid receptor
- cannabis
- endocannabinoid
- Huntington’s disease
- neuroprotection
- peptide cannabinoids
- Parkinson’s disease
- Prion disease
- Spinocerebellar ataxia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
